NCT05952076View on ClinicalTrials.gov

Impact of Bi-26 Supplementation on Weight Gain in Underweight Infants

PHASE3TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 3, 2023

Primary Completion Date

December 26, 2023

Study Completion Date

January 29, 2024

Conditions
UnderweightPaediatrics
Interventions
DIETARY_SUPPLEMENT

B. infantis Bi-26

A once-daily oral dose of Bi-26 will be provided to infants for 28 days.

DIETARY_SUPPLEMENT

Placebo

A once-daily oral dose of placebo maltodextrin will be provided to infants for 28 days

Trial Locations (5)

44000

Medical Facility A, Islamabad

Medical Facility B, Islamabad

Medical Facility C, Islamabad

46000

Medical Facility, Rawalpindi

54000

Medical Facility, Lahore

Sponsors
All Listed Sponsors
lead

Gates Medical Research Institute

OTHER

NCT05952076 - Impact of Bi-26 Supplementation on Weight Gain in Underweight Infants | Biotech Hunter | Biotech Hunter